Review



4e bp1  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Proteintech 4e bp1
    4e Bp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 164 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/4EBP1+Antibody/pm42894543-247-42-43
    Average 95 stars, based on 164 article reviews
    4e bp1 - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    Cell-Signaling:

    Article Title: Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy
    Article Snippet: Plasmids containing the insert SCD1 or GPX4 were procured from GenePharma (Shanghai, China). .. The primary antibodies against PTGS2, FTH, NCOA4, and SQSTM1/p62 were supplied by Santa Cruz Biotechnology (Santa Cruz, USA), the GPX4, SREBP1, PTEN, PI3K, AKT, mTOR, p-mTOR, 4E-BP1, and LC3 were obtained from Proteintech (Wuhan, China), and the p-PI3K, p-AKT, p-4E-BP1, and SCD1 were supplied by Cell Signaling Technology (MA, USA). ..

    Western Blot:

    Article Title: Multi-node inhibition targeting mTORC1, mTORC2 and PI3Kα potently inhibits the PI3K/AKT/mTOR pathway in endometrial and breast cancer models
    Article Snippet: .. Immunoblot analysis was performed using primary antibodies against the following targets: panAKT (Cell Signalling Technologies, 2920), phosAKT-Ser473 (Cell Signalling Technologies, 4058), S6 (Cell Signalling Technologies, 2317), phosS6-Ser235/Ser236 (Cell Signalling Technologies, 2211), 4E-BP1 (ProteinTech, 60246-1-Ig), phos4E-BP1-T37/46 (Cell Signalling Technologies, 2855), and vinculin (Cell Signalling Technologies, 13901). .. Secondary antibodies goat anti-rabbit-800 (926-32211) and donkey anti-mouse-680RD (926-68072) from Li-core were used.

    other:

    Article Title: Tumor-derived RAC1 A159V mutation promotes an immunosuppressive microenvironment that represses response to immune checkpoint inhibitor
    Article Snippet: Images were taken by the ChemiDoc Touch Imaging System (Bio-Rad).

    Incubation:

    Article Title: Implications for myofibrillar protein translation due to high-intensity muscle contraction via a rapamycin-insensitive mechanism.
    Article Snippet: .. The membranes were washed and incubated overnight at 4°C 161 with the following primary antibodies: Phospho-p70S6K (Thr389) (#9234), p70S6K (#2708), Phospho-162 rpS6 (Ser240/244) (#2215), rpS6 (#2217), eIF4E (#9742), eIF4G (#2498), Phospho-4E-BP1 (Thr37/46) 163 (#9459), Phospho-4E-BP1 (Ser65) (#9451), Phospho-4E-BP1 (Thr70) (#9455), 4E-BP1 (#9644), and 164 troponin I (#4002; All from Cell Signaling Technology); S6K2 (15268-1-AP) and myosin binding protein C1 165 (MyBP-C1) (22900-1-AP (both from Protein Tech Group Inc.); myosin (sc-32732), actin (sc-58670), 166 troponin C (sc-48347), and troponin T (sc-16663; All from Santa Cruz Biotechnology); myosin binding 167 protein C2 (MyBP-C2) (PA5-89164, Thermo Fisher Scientific Inc.). ..

    Article Title: Unilateral isometric contraction induces REDD1 and suppresses insulin‐stimulated mTORC1 and protein synthesis in non‐contracted muscle of male mice
    Article Snippet: Briefly, protein extracts (25 μg) from the gastrocnemius muscle were separated by 10% SDS–polyacrylamide gel electrophoresis (SDS–PAGE) and transferred onto 0.45 μm polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA) using a semidry transfer system (Bio‐Rad Laboratories). .. Membranes were blocked for 1 h using Can Get Signal PVDF Blocking Reagent (Toyobo), then incubated overnight at 4°C with the following primary antibodies: phospho‐Thr389 S6K1 (#9234), total S6K1 (#2708), total 4E‐BP1 (#9644), phospho‐Thr308 Akt (#13038), phospho‐Ser473 Akt (#4060), and pan‐Akt (#4691) (Cell Signaling Technology); REDD1 (#10638‐1‐AP, Proteintech Group). .. All primary antibodies were diluted 1:4000 in Can Get Signal Solution 1 (#NKB‐20, Toyobo).

    Binding Assay:

    Article Title: Implications for myofibrillar protein translation due to high-intensity muscle contraction via a rapamycin-insensitive mechanism.
    Article Snippet: .. The membranes were washed and incubated overnight at 4°C 161 with the following primary antibodies: Phospho-p70S6K (Thr389) (#9234), p70S6K (#2708), Phospho-162 rpS6 (Ser240/244) (#2215), rpS6 (#2217), eIF4E (#9742), eIF4G (#2498), Phospho-4E-BP1 (Thr37/46) 163 (#9459), Phospho-4E-BP1 (Ser65) (#9451), Phospho-4E-BP1 (Thr70) (#9455), 4E-BP1 (#9644), and 164 troponin I (#4002; All from Cell Signaling Technology); S6K2 (15268-1-AP) and myosin binding protein C1 165 (MyBP-C1) (22900-1-AP (both from Protein Tech Group Inc.); myosin (sc-32732), actin (sc-58670), 166 troponin C (sc-48347), and troponin T (sc-16663; All from Santa Cruz Biotechnology); myosin binding 167 protein C2 (MyBP-C2) (PA5-89164, Thermo Fisher Scientific Inc.). ..

    Blocking Assay:

    Article Title: Unilateral isometric contraction induces REDD1 and suppresses insulin‐stimulated mTORC1 and protein synthesis in non‐contracted muscle of male mice
    Article Snippet: Briefly, protein extracts (25 μg) from the gastrocnemius muscle were separated by 10% SDS–polyacrylamide gel electrophoresis (SDS–PAGE) and transferred onto 0.45 μm polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA) using a semidry transfer system (Bio‐Rad Laboratories). .. Membranes were blocked for 1 h using Can Get Signal PVDF Blocking Reagent (Toyobo), then incubated overnight at 4°C with the following primary antibodies: phospho‐Thr389 S6K1 (#9234), total S6K1 (#2708), total 4E‐BP1 (#9644), phospho‐Thr308 Akt (#13038), phospho‐Ser473 Akt (#4060), and pan‐Akt (#4691) (Cell Signaling Technology); REDD1 (#10638‐1‐AP, Proteintech Group). .. All primary antibodies were diluted 1:4000 in Can Get Signal Solution 1 (#NKB‐20, Toyobo).

    Recombinant:

    Article Title: PFKFB3 inhibition dictates the adaptive responses and cell fates in tumor cells.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies PFKFB3 Proteintech Cat# CL594-13763; RRID: AB_2919799 GAPDH Abclonal Cat# A19056; RRID: AB_2862549 mCherry Proteintech Cat# 26765-1-AP; RRID: AB_2876881 AMPK Abclonal Cat# A27740; RRID: AB_3720345 phospho-AMPK Abclonal Cat# AP1441; RRID: AB_3674046 phospho-4E-BP1 (Thr37) Proteintech 81812-4-RR; RRID: AB_3670507 4E-BP1 Proteintech Cat# 60246-1-Ig; RRID: AB_2881368 phospho-ACC1 (S79) Abclonal Cat# AP0298; RRID: AB_2770893 ACC1 Abclonal Cat# A19627; RRID: AB_3665497 ERK1/2 Abclonal Cat# A4782; RRID: AB_2863347 phospho-ERK1 (T202/Y204)/ERK2 (T185/Y187) R & D Cat# MAB1018; RRID: AB_2140122 HIF-1α Proteintech Cat# CR-20960; RRID: AB_2934339 Chemicals, peptides, and recombinant proteins PFK-015 MedChemExpress HY-12204 Dorsomorphin (Compound C) Selleck S7840 cobalt chloride Beyotime Y024817 Auxin Sigma I5148 Doxycycline Beyotime ST039A jetPRIME Polyplus 101000046 G418 Beyotime ST081 Puromycin Dihydrochloride Beyotime ST551 Gelatin StemCell 07903 Critical commercial assays CCK-8 assay Beyotime C0040 Cell cycle analysis Bestbio BB-4104 Seahorse XF96 analyzer Agilent Technologies 103792 Deposited data Raw and analyzed data This paper BioProject: PRJNA1506161 Experimental models: Cell lines PFKFB3-miniIAA7- mTurquoise2 HeLa cell lines This study N/A AtAFB2 HeLa (HeLa PFKFB3-AID) stable cell lines This study N/A Cdt1(30–120)-H1 HeLa PFKFB3-AID stable cell lines This study N/A inducible AtAFB2 HeLa PFKFB3-AID stable cell lines This study N/A AtAFB2 293T (HeLa PFKFB3-AID) stable cell lines This study N/A Oligonucleotides PFKFB3-gRNA: 5′-gactcctccaggaaacactg-3′ This study N/A donor-F:5′-ggagagaatagttttaaacattgtgtgttt-3′ This study N/A donor-R:5′-cttctgccatcaaaaaagtgcaaaag-3′ This study N/A Recombinant DNA PCW 57.1-AtAFB2-mCherry-weak NLS This study N/A FUGW-H1-mMaroon1-IRES-mKO2-Cdt1(30– 120) This study N/A (Continued on next page) iScience 29, 117768, November 20, 2026 15 .. HEK293T and HeLa cells were maintained in DMEM (11965092; Thermofisher) supplemented with 10% FBS (SE100-B; VisTech), penicillin/streptomycin (100 U/ml each) at 5% CO2 and 37◦C.

    CCK-8 Assay:

    Article Title: PFKFB3 inhibition dictates the adaptive responses and cell fates in tumor cells.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies PFKFB3 Proteintech Cat# CL594-13763; RRID: AB_2919799 GAPDH Abclonal Cat# A19056; RRID: AB_2862549 mCherry Proteintech Cat# 26765-1-AP; RRID: AB_2876881 AMPK Abclonal Cat# A27740; RRID: AB_3720345 phospho-AMPK Abclonal Cat# AP1441; RRID: AB_3674046 phospho-4E-BP1 (Thr37) Proteintech 81812-4-RR; RRID: AB_3670507 4E-BP1 Proteintech Cat# 60246-1-Ig; RRID: AB_2881368 phospho-ACC1 (S79) Abclonal Cat# AP0298; RRID: AB_2770893 ACC1 Abclonal Cat# A19627; RRID: AB_3665497 ERK1/2 Abclonal Cat# A4782; RRID: AB_2863347 phospho-ERK1 (T202/Y204)/ERK2 (T185/Y187) R & D Cat# MAB1018; RRID: AB_2140122 HIF-1α Proteintech Cat# CR-20960; RRID: AB_2934339 Chemicals, peptides, and recombinant proteins PFK-015 MedChemExpress HY-12204 Dorsomorphin (Compound C) Selleck S7840 cobalt chloride Beyotime Y024817 Auxin Sigma I5148 Doxycycline Beyotime ST039A jetPRIME Polyplus 101000046 G418 Beyotime ST081 Puromycin Dihydrochloride Beyotime ST551 Gelatin StemCell 07903 Critical commercial assays CCK-8 assay Beyotime C0040 Cell cycle analysis Bestbio BB-4104 Seahorse XF96 analyzer Agilent Technologies 103792 Deposited data Raw and analyzed data This paper BioProject: PRJNA1506161 Experimental models: Cell lines PFKFB3-miniIAA7- mTurquoise2 HeLa cell lines This study N/A AtAFB2 HeLa (HeLa PFKFB3-AID) stable cell lines This study N/A Cdt1(30–120)-H1 HeLa PFKFB3-AID stable cell lines This study N/A inducible AtAFB2 HeLa PFKFB3-AID stable cell lines This study N/A AtAFB2 293T (HeLa PFKFB3-AID) stable cell lines This study N/A Oligonucleotides PFKFB3-gRNA: 5′-gactcctccaggaaacactg-3′ This study N/A donor-F:5′-ggagagaatagttttaaacattgtgtgttt-3′ This study N/A donor-R:5′-cttctgccatcaaaaaagtgcaaaag-3′ This study N/A Recombinant DNA PCW 57.1-AtAFB2-mCherry-weak NLS This study N/A FUGW-H1-mMaroon1-IRES-mKO2-Cdt1(30– 120) This study N/A (Continued on next page) iScience 29, 117768, November 20, 2026 15 .. HEK293T and HeLa cells were maintained in DMEM (11965092; Thermofisher) supplemented with 10% FBS (SE100-B; VisTech), penicillin/streptomycin (100 U/ml each) at 5% CO2 and 37◦C.

    Cell Cycle Assay:

    Article Title: PFKFB3 inhibition dictates the adaptive responses and cell fates in tumor cells.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies PFKFB3 Proteintech Cat# CL594-13763; RRID: AB_2919799 GAPDH Abclonal Cat# A19056; RRID: AB_2862549 mCherry Proteintech Cat# 26765-1-AP; RRID: AB_2876881 AMPK Abclonal Cat# A27740; RRID: AB_3720345 phospho-AMPK Abclonal Cat# AP1441; RRID: AB_3674046 phospho-4E-BP1 (Thr37) Proteintech 81812-4-RR; RRID: AB_3670507 4E-BP1 Proteintech Cat# 60246-1-Ig; RRID: AB_2881368 phospho-ACC1 (S79) Abclonal Cat# AP0298; RRID: AB_2770893 ACC1 Abclonal Cat# A19627; RRID: AB_3665497 ERK1/2 Abclonal Cat# A4782; RRID: AB_2863347 phospho-ERK1 (T202/Y204)/ERK2 (T185/Y187) R & D Cat# MAB1018; RRID: AB_2140122 HIF-1α Proteintech Cat# CR-20960; RRID: AB_2934339 Chemicals, peptides, and recombinant proteins PFK-015 MedChemExpress HY-12204 Dorsomorphin (Compound C) Selleck S7840 cobalt chloride Beyotime Y024817 Auxin Sigma I5148 Doxycycline Beyotime ST039A jetPRIME Polyplus 101000046 G418 Beyotime ST081 Puromycin Dihydrochloride Beyotime ST551 Gelatin StemCell 07903 Critical commercial assays CCK-8 assay Beyotime C0040 Cell cycle analysis Bestbio BB-4104 Seahorse XF96 analyzer Agilent Technologies 103792 Deposited data Raw and analyzed data This paper BioProject: PRJNA1506161 Experimental models: Cell lines PFKFB3-miniIAA7- mTurquoise2 HeLa cell lines This study N/A AtAFB2 HeLa (HeLa PFKFB3-AID) stable cell lines This study N/A Cdt1(30–120)-H1 HeLa PFKFB3-AID stable cell lines This study N/A inducible AtAFB2 HeLa PFKFB3-AID stable cell lines This study N/A AtAFB2 293T (HeLa PFKFB3-AID) stable cell lines This study N/A Oligonucleotides PFKFB3-gRNA: 5′-gactcctccaggaaacactg-3′ This study N/A donor-F:5′-ggagagaatagttttaaacattgtgtgttt-3′ This study N/A donor-R:5′-cttctgccatcaaaaaagtgcaaaag-3′ This study N/A Recombinant DNA PCW 57.1-AtAFB2-mCherry-weak NLS This study N/A FUGW-H1-mMaroon1-IRES-mKO2-Cdt1(30– 120) This study N/A (Continued on next page) iScience 29, 117768, November 20, 2026 15 .. HEK293T and HeLa cells were maintained in DMEM (11965092; Thermofisher) supplemented with 10% FBS (SE100-B; VisTech), penicillin/streptomycin (100 U/ml each) at 5% CO2 and 37◦C.

    Stable Transfection:

    Article Title: PFKFB3 inhibition dictates the adaptive responses and cell fates in tumor cells.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies PFKFB3 Proteintech Cat# CL594-13763; RRID: AB_2919799 GAPDH Abclonal Cat# A19056; RRID: AB_2862549 mCherry Proteintech Cat# 26765-1-AP; RRID: AB_2876881 AMPK Abclonal Cat# A27740; RRID: AB_3720345 phospho-AMPK Abclonal Cat# AP1441; RRID: AB_3674046 phospho-4E-BP1 (Thr37) Proteintech 81812-4-RR; RRID: AB_3670507 4E-BP1 Proteintech Cat# 60246-1-Ig; RRID: AB_2881368 phospho-ACC1 (S79) Abclonal Cat# AP0298; RRID: AB_2770893 ACC1 Abclonal Cat# A19627; RRID: AB_3665497 ERK1/2 Abclonal Cat# A4782; RRID: AB_2863347 phospho-ERK1 (T202/Y204)/ERK2 (T185/Y187) R & D Cat# MAB1018; RRID: AB_2140122 HIF-1α Proteintech Cat# CR-20960; RRID: AB_2934339 Chemicals, peptides, and recombinant proteins PFK-015 MedChemExpress HY-12204 Dorsomorphin (Compound C) Selleck S7840 cobalt chloride Beyotime Y024817 Auxin Sigma I5148 Doxycycline Beyotime ST039A jetPRIME Polyplus 101000046 G418 Beyotime ST081 Puromycin Dihydrochloride Beyotime ST551 Gelatin StemCell 07903 Critical commercial assays CCK-8 assay Beyotime C0040 Cell cycle analysis Bestbio BB-4104 Seahorse XF96 analyzer Agilent Technologies 103792 Deposited data Raw and analyzed data This paper BioProject: PRJNA1506161 Experimental models: Cell lines PFKFB3-miniIAA7- mTurquoise2 HeLa cell lines This study N/A AtAFB2 HeLa (HeLa PFKFB3-AID) stable cell lines This study N/A Cdt1(30–120)-H1 HeLa PFKFB3-AID stable cell lines This study N/A inducible AtAFB2 HeLa PFKFB3-AID stable cell lines This study N/A AtAFB2 293T (HeLa PFKFB3-AID) stable cell lines This study N/A Oligonucleotides PFKFB3-gRNA: 5′-gactcctccaggaaacactg-3′ This study N/A donor-F:5′-ggagagaatagttttaaacattgtgtgttt-3′ This study N/A donor-R:5′-cttctgccatcaaaaaagtgcaaaag-3′ This study N/A Recombinant DNA PCW 57.1-AtAFB2-mCherry-weak NLS This study N/A FUGW-H1-mMaroon1-IRES-mKO2-Cdt1(30– 120) This study N/A (Continued on next page) iScience 29, 117768, November 20, 2026 15 .. HEK293T and HeLa cells were maintained in DMEM (11965092; Thermofisher) supplemented with 10% FBS (SE100-B; VisTech), penicillin/streptomycin (100 U/ml each) at 5% CO2 and 37◦C.



    Similar Products

    96
    Cell Signaling Technology Inc eukaryotic translation initiation factor 4e binding protein
    Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated <t>4E-BP1.</t> (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = <t>Eukaryotic</t> translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
    Eukaryotic Translation Initiation Factor 4e Binding Protein, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/4E-BP1+Antibody/pmc12816905-99-78-87
    Average 96 stars, based on 1 article reviews
    eukaryotic translation initiation factor 4e binding protein - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc phospho 4e bp1
    Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated <t>4E-BP1.</t> (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = <t>Eukaryotic</t> translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
    Phospho 4e Bp1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/Phospho-4E-BP1+(Thr37%2F46)+Antibody/pm42986687-108-17-20
    Average 96 stars, based on 1 article reviews
    phospho 4e bp1 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology p 4e bp1
    Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated <t>4E-BP1.</t> (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = <t>Eukaryotic</t> translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
    P 4e Bp1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/Phospho-EIF4EBP1-T37%2F46+Rabbit+pAb/pm42915814-22-6-14
    Average 94 stars, based on 1 article reviews
    p 4e bp1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    Proteintech 4e bp1
    Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated <t>4E-BP1.</t> (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = <t>Eukaryotic</t> translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
    4e Bp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/4EBP1+Antibody/pm42894543-247-42-43
    Average 95 stars, based on 1 article reviews
    4e bp1 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit anti 4ebp1
    Both monthly and biweekly M021 dosing regimens maintain low muscle glycogen levels (A) Experimental design: 4-month-old KO mice received 4 biweekly administrations of M021 (20 mg/kg; debulking phase). The animals were then divided into two groups receiving either monthly or biweekly dosing. The animals were analyzed at 3, 4, and 6 months. (B) Glycogen levels in treated KO at the indicated time points [month 3: n = 6 (biweekly), n = 5–6 (monthly); month 4: n = 5 (biweekly), n = 5 (monthly); month 6: n = 3 (biweekly), n = 4 (monthly)]. Age-matched wild-type (WT, n = 11–13) and untreated KO ( n = 12) mice were used as controls. (C) PAS staining for glycogen in the gastrocnemius muscle from untreated (KO), M021-treated, and WT mice. Original magnification, ×200. Scale bars, 50 μm. Additional images are shown in  and  . (D and E) Western blot of whole muscle lysates with the indicated antibodies at the 4-month-time point. GAPDH and vinculin were used as loading controls. Graphical representation of the data in (D) and (E). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, by one-way ANOVA with Tukey’s multiple comparisons.
    Rabbit Anti 4ebp1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/4E-BP1+Rabbit+mAb/pmc13744927-301-40-42
    Average 96 stars, based on 1 article reviews
    rabbit anti 4ebp1 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc phospho 4ebp1
    a-c, Representative images of phosphorylated S6 (p-S6, green), RBPMS (red), and DAPI (blue) staining in whole retinal sections (left), with magnified views (middle), and normalization of p-S6/RBPMS intensity (right) from pre-birth (E18.5) embryos, 5 min, and 12 hr postnatal pups. Scale bars, 200 μm (whole retinal section); 50 μm (magnified views). d, Quantification showing that the percentage of p-S6-positive RGCs significantly decreases after birth. Each circle represents the mean percentage of p-S6-positive RGCs among total RBPMS-positive RGCs in the ganglion cell layer (GCL) of each retina. For each whole retina section, all RGCs were included in the quantification. ****p < 0.0001; N = 4, 3 and 3 biological replicates for pre-birth, 5 min post-birth and 12 hr post-birth groups, respectively; unpaired Welch’s t-test. e, Western blot showing that mTOR activity markers (p-S6, p-S6K, and <t>p-4EBP1)</t> decrease markedly in brain, heart, and hindlimb muscles within 5 min after birth. Quadriceps femoris muscles and biceps femoris muscles from both left and right hindlimbs were pooled together to generate hindlimb muscles sample for each mouse. f, Quantification of Western blot result shown in (e) . *p < 0.05, **p < 0.01, ***p < 0.001; N = 3 and 4 biological replicates for pre-birth and 5 min post birth, respectively; unpaired Welch’s t-test. g, Experimental scheme (left) illustrating conditions with deprivation of maternal nutrient supply or inhibition of breathing onset. Representative images (right) of p-S6, RBPMS, and DAPI staining in whole retinal sections (from newborns at 5 min after birth) and corresponding magnified views under the indicated conditions. 200 μm (whole retinal section); 50 μm (magnified views). h, Quantification showing the percentage of p-S6-positive RGCs under different conditions. At 5 min after birth, deprivation of maternal nutrient supply does not alter p-S6 levels, whereas initiation of breathing significantly decreases mTOR activity. ***p < 0.001; n.s., not significant; N = 5, 3, 3 and 3 biological replicates for (“+ nutrient - breathing”), (“- nutrient - breathing”), (“+ nutrient + breathing”) and (“- nutrient + breathing”) groups, respectively; unpaired Welch’s t-test.
    Phospho 4ebp1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/Phospho-4E-BP1+(Thr37%2F46)+Rabbit+mAb/bio_rxiv__64898__2026__10__03__756425-223-11-13
    Average 96 stars, based on 1 article reviews
    phospho 4ebp1 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology phospho 4e bp1 thr37 46
    a-c, Representative images of phosphorylated S6 (p-S6, green), RBPMS (red), and DAPI (blue) staining in whole retinal sections (left), with magnified views (middle), and normalization of p-S6/RBPMS intensity (right) from pre-birth (E18.5) embryos, 5 min, and 12 hr postnatal pups. Scale bars, 200 μm (whole retinal section); 50 μm (magnified views). d, Quantification showing that the percentage of p-S6-positive RGCs significantly decreases after birth. Each circle represents the mean percentage of p-S6-positive RGCs among total RBPMS-positive RGCs in the ganglion cell layer (GCL) of each retina. For each whole retina section, all RGCs were included in the quantification. ****p < 0.0001; N = 4, 3 and 3 biological replicates for pre-birth, 5 min post-birth and 12 hr post-birth groups, respectively; unpaired Welch’s t-test. e, Western blot showing that mTOR activity markers (p-S6, p-S6K, and <t>p-4EBP1)</t> decrease markedly in brain, heart, and hindlimb muscles within 5 min after birth. Quadriceps femoris muscles and biceps femoris muscles from both left and right hindlimbs were pooled together to generate hindlimb muscles sample for each mouse. f, Quantification of Western blot result shown in (e) . *p < 0.05, **p < 0.01, ***p < 0.001; N = 3 and 4 biological replicates for pre-birth and 5 min post birth, respectively; unpaired Welch’s t-test. g, Experimental scheme (left) illustrating conditions with deprivation of maternal nutrient supply or inhibition of breathing onset. Representative images (right) of p-S6, RBPMS, and DAPI staining in whole retinal sections (from newborns at 5 min after birth) and corresponding magnified views under the indicated conditions. 200 μm (whole retinal section); 50 μm (magnified views). h, Quantification showing the percentage of p-S6-positive RGCs under different conditions. At 5 min after birth, deprivation of maternal nutrient supply does not alter p-S6 levels, whereas initiation of breathing significantly decreases mTOR activity. ***p < 0.001; n.s., not significant; N = 5, 3, 3 and 3 biological replicates for (“+ nutrient - breathing”), (“- nutrient - breathing”), (“+ nutrient + breathing”) and (“- nutrient + breathing”) groups, respectively; unpaired Welch’s t-test.
    Phospho 4e Bp1 Thr37 46, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/Phospho-EIF4EBP1-T37%2F46+Rabbit+pAb/10__3390_slash_cancers18203257-69-38-39
    Average 94 stars, based on 1 article reviews
    phospho 4e bp1 thr37 46 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc 4e bp1
    a-c, Representative images of phosphorylated S6 (p-S6, green), RBPMS (red), and DAPI (blue) staining in whole retinal sections (left), with magnified views (middle), and normalization of p-S6/RBPMS intensity (right) from pre-birth (E18.5) embryos, 5 min, and 12 hr postnatal pups. Scale bars, 200 μm (whole retinal section); 50 μm (magnified views). d, Quantification showing that the percentage of p-S6-positive RGCs significantly decreases after birth. Each circle represents the mean percentage of p-S6-positive RGCs among total RBPMS-positive RGCs in the ganglion cell layer (GCL) of each retina. For each whole retina section, all RGCs were included in the quantification. ****p < 0.0001; N = 4, 3 and 3 biological replicates for pre-birth, 5 min post-birth and 12 hr post-birth groups, respectively; unpaired Welch’s t-test. e, Western blot showing that mTOR activity markers (p-S6, p-S6K, and <t>p-4EBP1)</t> decrease markedly in brain, heart, and hindlimb muscles within 5 min after birth. Quadriceps femoris muscles and biceps femoris muscles from both left and right hindlimbs were pooled together to generate hindlimb muscles sample for each mouse. f, Quantification of Western blot result shown in (e) . *p < 0.05, **p < 0.01, ***p < 0.001; N = 3 and 4 biological replicates for pre-birth and 5 min post birth, respectively; unpaired Welch’s t-test. g, Experimental scheme (left) illustrating conditions with deprivation of maternal nutrient supply or inhibition of breathing onset. Representative images (right) of p-S6, RBPMS, and DAPI staining in whole retinal sections (from newborns at 5 min after birth) and corresponding magnified views under the indicated conditions. 200 μm (whole retinal section); 50 μm (magnified views). h, Quantification showing the percentage of p-S6-positive RGCs under different conditions. At 5 min after birth, deprivation of maternal nutrient supply does not alter p-S6 levels, whereas initiation of breathing significantly decreases mTOR activity. ***p < 0.001; n.s., not significant; N = 5, 3, 3 and 3 biological replicates for (“+ nutrient - breathing”), (“- nutrient - breathing”), (“+ nutrient + breathing”) and (“- nutrient + breathing”) groups, respectively; unpaired Welch’s t-test.
    4e Bp1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/Phospho-4E-BP1+(Thr37%2F46)+Rabbit+mAb/pm42850593-88-36-45
    Average 96 stars, based on 1 article reviews
    4e bp1 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc yap
    Q209R preferentially engages <t>FAK‐YAP</t> signaling. (A) Western blot analysis of GNAQ, BAP1, Melan‐A, p‐ERK1/2 (Thr202/Tyr204), ERK1/2, FRA1, p‐AKT (Ser473), AKT, <t>p‐4EBP1</t> <t>(Ser65),</t> and 4EBP1 expression in mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . HSP90 was used as an internal loading control. (B) Quantification of the relative ratio between p‐AKT (Ser473) and AKT in Q209R and Q209L UM cell lines from (A). (C) Quantification of the relative ratio between p‐4EBP1 (Ser65) and 4EBP1 in Q209R and Q209L UM cell lines from (A). (D) Western blot analysis of p‐FAK (Tyr397), FAK, p‐YAP (Ser127), and YAP in mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . HSP90 was used as an internal loading control. (E) Quantification of the relative ratio between p‐FAK (Tyr397) and FAK in Q209R and Q209L UM cell lines from (D). (F) Quantification of the relative ratio between p‐YAP (Ser127) and YAP in Q209R and Q209L UM cell lines from (D). Orthotopic tumor‐derived cell lines (QBM12.1 [Q209R], QBM12.3 [Q209R], QBM24 [Q209R], QBM45 [Q209L], QBM47 [Q209L]) and liver metastatic lines (QBM12L [Q209R], QBM12L2 [Q209R], QBM51L [Q209L], QBM53L [Q209L]) were used in A–F. (G) Representative IHC images showing YAP expression in primary tumors from Gnaq CA ; Bap1 CKO ; Myc CKI mice harboring either GNAQ Q209R or GNAQ Q209L . (H) Quantification of the nuclear‐to‐cytoplasmic YAP intensity ratio (H‐score) among primary tumors from Gnaq CA ; Bap1 CKO ; Myc CKI mice harboring either GNAQ Q209R or GNAQ Q209L . (I) Representative IHC images showing YAP expression in liver metastasis derived from intrasplenic transplantation of mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . (J) Quantification of nuclear YAP intensity (H‐score) among liver metastasis derived from intrasplenic transplantation of mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L .
    Yap, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4e+bp1/Phospho-4E-BP1+(Ser65)+Antibody/pmc13635764-42-53-54
    Average 96 stars, based on 1 article reviews
    yap - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

    Journal: Journal of Sport and Health Science

    Article Title: Weightlifting outperforms voluntary wheel running for improving adiposity and insulin sensitivity in obese mice

    doi: 10.1016/j.jshs.2025.101100

    Figure Lengend Snippet: Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

    Article Snippet: Primary antibodies used for analysis were from Cell Signaling Technologies (Danvers, MA, USA) and diluted 1:1000 unless otherwise stated as follows: protein kinase B (Akt; 1:500; #4691; Cell Signaling Technologies), phospho-Akt (pAkt) S473 (1:500; #9271; Cell Signaling Technologies), Ubiquitin (#3933; Cell Signaling Technologies), microtubule-associated protein light chain 3 (LC3 II/I; #4018; Cell Signaling Technologies), cytochrome c oxidase subunit 4(COX4; #11967; Cell Signaling Technologies), Akt substrate 160 (AS160 S318; #8619; Cell Signaling Technologies), AS160 T642 (#8881; Cell Signaling Technologies), eukaryotic translation initiation factor 4E binding protein (4E-BP1; #9452; Cell Signaling Technologies), and glyceraldehyde 3 phosphate dehydrogenase (GAPDH; #2118; Cell Signaling Technologies).

    Techniques: Phospho-proteomics, Injection, Western Blot, Muscles, Ubiquitin Proteomics, Staining, Binding Assay

    Both monthly and biweekly M021 dosing regimens maintain low muscle glycogen levels (A) Experimental design: 4-month-old KO mice received 4 biweekly administrations of M021 (20 mg/kg; debulking phase). The animals were then divided into two groups receiving either monthly or biweekly dosing. The animals were analyzed at 3, 4, and 6 months. (B) Glycogen levels in treated KO at the indicated time points [month 3: n = 6 (biweekly), n = 5–6 (monthly); month 4: n = 5 (biweekly), n = 5 (monthly); month 6: n = 3 (biweekly), n = 4 (monthly)]. Age-matched wild-type (WT, n = 11–13) and untreated KO ( n = 12) mice were used as controls. (C) PAS staining for glycogen in the gastrocnemius muscle from untreated (KO), M021-treated, and WT mice. Original magnification, ×200. Scale bars, 50 μm. Additional images are shown in  and  . (D and E) Western blot of whole muscle lysates with the indicated antibodies at the 4-month-time point. GAPDH and vinculin were used as loading controls. Graphical representation of the data in (D) and (E). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, by one-way ANOVA with Tukey’s multiple comparisons.

    Journal: Molecular Therapy Advances

    Article Title: A novel technology-driven enzyme replacement therapy for Pompe disease

    doi: 10.1016/j.omta.2026.201867

    Figure Lengend Snippet: Both monthly and biweekly M021 dosing regimens maintain low muscle glycogen levels (A) Experimental design: 4-month-old KO mice received 4 biweekly administrations of M021 (20 mg/kg; debulking phase). The animals were then divided into two groups receiving either monthly or biweekly dosing. The animals were analyzed at 3, 4, and 6 months. (B) Glycogen levels in treated KO at the indicated time points [month 3: n = 6 (biweekly), n = 5–6 (monthly); month 4: n = 5 (biweekly), n = 5 (monthly); month 6: n = 3 (biweekly), n = 4 (monthly)]. Age-matched wild-type (WT, n = 11–13) and untreated KO ( n = 12) mice were used as controls. (C) PAS staining for glycogen in the gastrocnemius muscle from untreated (KO), M021-treated, and WT mice. Original magnification, ×200. Scale bars, 50 μm. Additional images are shown in and . (D and E) Western blot of whole muscle lysates with the indicated antibodies at the 4-month-time point. GAPDH and vinculin were used as loading controls. Graphical representation of the data in (D) and (E). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, by one-way ANOVA with Tukey’s multiple comparisons.

    Article Snippet: The following primary antibodies were used: rabbit anti-GAA (Abcam ab137068), mouse anti-p62 (Abcam ab56416), rabbit anti-GAPDH (Abcam ab9485), rat anti-LAMP-1 (BD 553792), mouse anti-Galectin-3 (Santa Cruz SC-32790), mouse anti-Vinculin (Sigma V9131), rabbit anti-LC3 (Sigma L7543), rabbit anti-non-phospho-4EBP1 (Thr46; CST 4923), rabbit anti-4EBP1 (CST 9644), rabbit anti-AMPK alpha (CST 5831), and rabbit anti-phospho-AMPK alpha (CST 2535).

    Techniques: Periodic Acid-Schiff Staining, Western Blot

    a-c, Representative images of phosphorylated S6 (p-S6, green), RBPMS (red), and DAPI (blue) staining in whole retinal sections (left), with magnified views (middle), and normalization of p-S6/RBPMS intensity (right) from pre-birth (E18.5) embryos, 5 min, and 12 hr postnatal pups. Scale bars, 200 μm (whole retinal section); 50 μm (magnified views). d, Quantification showing that the percentage of p-S6-positive RGCs significantly decreases after birth. Each circle represents the mean percentage of p-S6-positive RGCs among total RBPMS-positive RGCs in the ganglion cell layer (GCL) of each retina. For each whole retina section, all RGCs were included in the quantification. ****p < 0.0001; N = 4, 3 and 3 biological replicates for pre-birth, 5 min post-birth and 12 hr post-birth groups, respectively; unpaired Welch’s t-test. e, Western blot showing that mTOR activity markers (p-S6, p-S6K, and p-4EBP1) decrease markedly in brain, heart, and hindlimb muscles within 5 min after birth. Quadriceps femoris muscles and biceps femoris muscles from both left and right hindlimbs were pooled together to generate hindlimb muscles sample for each mouse. f, Quantification of Western blot result shown in (e) . *p < 0.05, **p < 0.01, ***p < 0.001; N = 3 and 4 biological replicates for pre-birth and 5 min post birth, respectively; unpaired Welch’s t-test. g, Experimental scheme (left) illustrating conditions with deprivation of maternal nutrient supply or inhibition of breathing onset. Representative images (right) of p-S6, RBPMS, and DAPI staining in whole retinal sections (from newborns at 5 min after birth) and corresponding magnified views under the indicated conditions. 200 μm (whole retinal section); 50 μm (magnified views). h, Quantification showing the percentage of p-S6-positive RGCs under different conditions. At 5 min after birth, deprivation of maternal nutrient supply does not alter p-S6 levels, whereas initiation of breathing significantly decreases mTOR activity. ***p < 0.001; n.s., not significant; N = 5, 3, 3 and 3 biological replicates for (“+ nutrient - breathing”), (“- nutrient - breathing”), (“+ nutrient + breathing”) and (“- nutrient + breathing”) groups, respectively; unpaired Welch’s t-test.

    Journal: bioRxiv

    Article Title: The Onset of Breathing at Birth Switches Off Regenerative Capacity

    doi: 10.64898/2026.10.03.756425

    Figure Lengend Snippet: a-c, Representative images of phosphorylated S6 (p-S6, green), RBPMS (red), and DAPI (blue) staining in whole retinal sections (left), with magnified views (middle), and normalization of p-S6/RBPMS intensity (right) from pre-birth (E18.5) embryos, 5 min, and 12 hr postnatal pups. Scale bars, 200 μm (whole retinal section); 50 μm (magnified views). d, Quantification showing that the percentage of p-S6-positive RGCs significantly decreases after birth. Each circle represents the mean percentage of p-S6-positive RGCs among total RBPMS-positive RGCs in the ganglion cell layer (GCL) of each retina. For each whole retina section, all RGCs were included in the quantification. ****p < 0.0001; N = 4, 3 and 3 biological replicates for pre-birth, 5 min post-birth and 12 hr post-birth groups, respectively; unpaired Welch’s t-test. e, Western blot showing that mTOR activity markers (p-S6, p-S6K, and p-4EBP1) decrease markedly in brain, heart, and hindlimb muscles within 5 min after birth. Quadriceps femoris muscles and biceps femoris muscles from both left and right hindlimbs were pooled together to generate hindlimb muscles sample for each mouse. f, Quantification of Western blot result shown in (e) . *p < 0.05, **p < 0.01, ***p < 0.001; N = 3 and 4 biological replicates for pre-birth and 5 min post birth, respectively; unpaired Welch’s t-test. g, Experimental scheme (left) illustrating conditions with deprivation of maternal nutrient supply or inhibition of breathing onset. Representative images (right) of p-S6, RBPMS, and DAPI staining in whole retinal sections (from newborns at 5 min after birth) and corresponding magnified views under the indicated conditions. 200 μm (whole retinal section); 50 μm (magnified views). h, Quantification showing the percentage of p-S6-positive RGCs under different conditions. At 5 min after birth, deprivation of maternal nutrient supply does not alter p-S6 levels, whereas initiation of breathing significantly decreases mTOR activity. ***p < 0.001; n.s., not significant; N = 5, 3, 3 and 3 biological replicates for (“+ nutrient - breathing”), (“- nutrient - breathing”), (“+ nutrient + breathing”) and (“- nutrient + breathing”) groups, respectively; unpaired Welch’s t-test.

    Article Snippet: Primary antibodies against phospho-S6 (Ser235/236, CST 4858S), phospho-S6K (Thr389, CST 9234T), phospho-4EBP1 (Thr37/46, CST 2855T), total S6 (CST 2217T), S6K (CST 9202S), 4EBP1(CST 9644T) and actin (CST 4970T) were obtained from Cell Signaling Technology.

    Techniques: Staining, Western Blot, Activity Assay, Muscles, Inhibition

    Q209R preferentially engages FAK‐YAP signaling. (A) Western blot analysis of GNAQ, BAP1, Melan‐A, p‐ERK1/2 (Thr202/Tyr204), ERK1/2, FRA1, p‐AKT (Ser473), AKT, p‐4EBP1 (Ser65), and 4EBP1 expression in mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . HSP90 was used as an internal loading control. (B) Quantification of the relative ratio between p‐AKT (Ser473) and AKT in Q209R and Q209L UM cell lines from (A). (C) Quantification of the relative ratio between p‐4EBP1 (Ser65) and 4EBP1 in Q209R and Q209L UM cell lines from (A). (D) Western blot analysis of p‐FAK (Tyr397), FAK, p‐YAP (Ser127), and YAP in mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . HSP90 was used as an internal loading control. (E) Quantification of the relative ratio between p‐FAK (Tyr397) and FAK in Q209R and Q209L UM cell lines from (D). (F) Quantification of the relative ratio between p‐YAP (Ser127) and YAP in Q209R and Q209L UM cell lines from (D). Orthotopic tumor‐derived cell lines (QBM12.1 [Q209R], QBM12.3 [Q209R], QBM24 [Q209R], QBM45 [Q209L], QBM47 [Q209L]) and liver metastatic lines (QBM12L [Q209R], QBM12L2 [Q209R], QBM51L [Q209L], QBM53L [Q209L]) were used in A–F. (G) Representative IHC images showing YAP expression in primary tumors from Gnaq CA ; Bap1 CKO ; Myc CKI mice harboring either GNAQ Q209R or GNAQ Q209L . (H) Quantification of the nuclear‐to‐cytoplasmic YAP intensity ratio (H‐score) among primary tumors from Gnaq CA ; Bap1 CKO ; Myc CKI mice harboring either GNAQ Q209R or GNAQ Q209L . (I) Representative IHC images showing YAP expression in liver metastasis derived from intrasplenic transplantation of mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . (J) Quantification of nuclear YAP intensity (H‐score) among liver metastasis derived from intrasplenic transplantation of mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L .

    Journal: Pigment Cell & Melanoma Research

    Article Title: Allele‐Specific GNAQ Q209 Mutations Reveal Context‐Dependent Oncogenic Programs in Uveal Melanoma

    doi: 10.1111/pcmr.70121

    Figure Lengend Snippet: Q209R preferentially engages FAK‐YAP signaling. (A) Western blot analysis of GNAQ, BAP1, Melan‐A, p‐ERK1/2 (Thr202/Tyr204), ERK1/2, FRA1, p‐AKT (Ser473), AKT, p‐4EBP1 (Ser65), and 4EBP1 expression in mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . HSP90 was used as an internal loading control. (B) Quantification of the relative ratio between p‐AKT (Ser473) and AKT in Q209R and Q209L UM cell lines from (A). (C) Quantification of the relative ratio between p‐4EBP1 (Ser65) and 4EBP1 in Q209R and Q209L UM cell lines from (A). (D) Western blot analysis of p‐FAK (Tyr397), FAK, p‐YAP (Ser127), and YAP in mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . HSP90 was used as an internal loading control. (E) Quantification of the relative ratio between p‐FAK (Tyr397) and FAK in Q209R and Q209L UM cell lines from (D). (F) Quantification of the relative ratio between p‐YAP (Ser127) and YAP in Q209R and Q209L UM cell lines from (D). Orthotopic tumor‐derived cell lines (QBM12.1 [Q209R], QBM12.3 [Q209R], QBM24 [Q209R], QBM45 [Q209L], QBM47 [Q209L]) and liver metastatic lines (QBM12L [Q209R], QBM12L2 [Q209R], QBM51L [Q209L], QBM53L [Q209L]) were used in A–F. (G) Representative IHC images showing YAP expression in primary tumors from Gnaq CA ; Bap1 CKO ; Myc CKI mice harboring either GNAQ Q209R or GNAQ Q209L . (H) Quantification of the nuclear‐to‐cytoplasmic YAP intensity ratio (H‐score) among primary tumors from Gnaq CA ; Bap1 CKO ; Myc CKI mice harboring either GNAQ Q209R or GNAQ Q209L . (I) Representative IHC images showing YAP expression in liver metastasis derived from intrasplenic transplantation of mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L . (J) Quantification of nuclear YAP intensity (H‐score) among liver metastasis derived from intrasplenic transplantation of mouse UM cell lines harboring GNAQ Q209R or GNAQ Q209L .

    Article Snippet: Antibodies against GNAQ (CST, #14373, RRID:AB_2665457), BAP1 (Abcam, ab255611), Melan‐A (Abcam, ab210546, RRID:AB_2889292), ERK1/2 (CST, #4695, RRID:AB_390779), p‐ERK1/2 (Thr202/Tyr204) (CST, #4370, RRID:AB_2315112), FRA1 (Abcam, ab252421, RRID:AB_2904513), AKT (CST, #4691, RRID:AB_915783), p‐AKT (Ser473) (CST, #4060, RRID:AB_2315049), p‐FAK (Tyr397) (CST, #8556, RRID:AB_10891442), FAK (CST, #3285, RRID:AB_2269034), 4E‐BP1 (CST, #9452, RRID:AB_331692), p‐4E‐BP1 (Ser65; CST, #9451, RRID:AB_330947), YAP (CST, #4912, RRID:AB_2218911), and p‐YAP (Ser127) (CST, #4911, RRID:AB_2218913) were used at 1:1000 as indicated.

    Techniques: Western Blot, Analysis, Expressing, Control, Derivative Assay, Transplantation Assay